Cargando…
Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
The incidence rate and mortality rate of cervical cancer have steadily increased in young women in China. Therefore, it is critical to improve HPV vaccination rates, particularly for the younger population. There are currently five types of prophylactic vaccines in China: bivalent HPV vaccine (AS04-...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040563/ https://www.ncbi.nlm.nih.gov/pubmed/36993948 http://dx.doi.org/10.3389/fimmu.2023.1112750 |